Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Set To Become Public Company In 2023 As Novartis Confirms Spin-Off
No Formal Offers Received For Sandoz To Date But Novartis Would Have To Consider
Aug 25 2022
•
By
Dean Rudge
Novartis received no formal or binding offers • Source: Shutterstock
More from Deals
More from Business